We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Allergan Announces $300 Million Settlement for Loestrin Litigation
Allergan Announces $300 Million Settlement for Loestrin Litigation
Allergan reached a $300 million settlement to resolve a class action lawsuit over the oral contraceptives Loestrin 24 Fe (norethindrone acetate, ethinyl estradiol, and ferrous fumarate) and Minastrin 24 Fe (norethindrone acetate and ethinyl estradiol/ferrous fumarate).